National TB Control Program,pakista Pharmaceutical Import Profile — Pakistan (DGFT 2022–2026)

Name: National TB Control Program,pakista Pharmaceutical Import Records from India — 2 Products, $650.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

National TB Control Program,pakista — Pharmaceutical Importer Profile (2026) | 2 Products, $650.0K Trade | TransData Nexus

National TB Control Program,pakista

Pharmaceutical Importer · Pakistan · Tuberculosis Medications Focus · $650.0K Total Trade · DGFT Verified

National TB Control Program,pakista is a pharmaceutical importer based in Pakistan with a total trade value of $650.0K across 2 products in 1 therapeutic categories. Based on 13 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. National TB Control Program,pakista sources from 1 verified Indian supplier, with Macleods Pharmaceuticals Limited accounting for 100.0% of imports.

National TB Control Program,pakista — Import Portfolio & Supplier Network

National TB Control Program,pakista import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to National TB Control Program,pakista?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Macleods Pharmaceuticals Limited	$373.0K	11	100.0%

National TB Control Program,pakista sources from 1 verified Indian supplier across 11 distinct formulations. The sourcing is highly concentrated — Macleods Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Ethambutol hcl 100MG dispersible tablets(3432 pks) (ps. 10 x 10)	$50.0K	1
Rifampicin 150MG+ isoniazid 75MG+ pyrazinamide 400MG+ ethambutol 275MG tablets (12627 pks) (ps. 24 x 28)	$50.0K	1
Rifampicin 150MG+isoniazid 75MG+pyrazinamide 400 MG+ethambutol 275MG tablets (12965 pks) (ps. 24 x 28)	$50.0K	1
Rifampicin 75MG/isoniazid 50MG dispersible tablets(43768 pks)(ps.3 x28)	$50.0K	1
Rifampicin 75MG/isoniazid 50MG dispersible tablets(43769 pks)(ps.3 x28)	$50.0K	1
Rifampicin 75MG/isoniazid 50MG/pyrazinamide 150MG disp tabs(22473 pks)(ps.3 x28)	$50.0K	1
Rifampicin 75MG/isoniazid 50MG/pyrazinamide 150MG disp tabs(22474 pks)(ps.3 x28)	$50.0K	1
Rifampicin 150MG+ isoniazid 75MG+ pyrazinamide 400MG+ ethambutol 275MG tablets (337 pks) (ps. 24 x 28)	$23.0K	1
Net cont item sr.no.2-rifampicin 1272.8016 kgs & isoniazid 636.4008	$0	1
Net cont item sr.no.4-rifampicin 33.9696kgs,isoniazid 16.9846 kgs,pyrazinamide90.5856 kgs,ethambutol hcl 62.2776	$0	1
Net cont item sr.no.6-rifampicin 1306.872kgs,isoniazid 653.436kgs,pyrazinamide 3484.992kgs,ethambutol hcl	$0	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Pyrazinamide	Tuberculosis Medications	$350.0K	7	0.0%	10
2	Ethambutol	Tuberculosis Medications	$300.0K	6	0.0%	16

National TB Control Program,pakista imports 2 pharmaceutical products across 1 categories into Pakistan totaling $650.0K.

National TB Control Program,pakista — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

The National TB Control Program (NTP) of Pakistan is a government initiative operating under the Ministry of National Health Services, Regulations, and Coordination. Its mission is to eliminate tuberculosis (TB) from the country by providing free diagnostic and treatment services across a network of over 1,700 TB care facilities in both public and private sectors. In 2022, the program successfully treated more than 424,000 TB cases, demonstrating its significant role in Pakistan's healthcare system. (cmu.gov.pk)

As a government entity, NTP is not a commercial pharmaceutical buyer or importer. Instead, it collaborates with various stakeholders, including international organizations and local suppliers, to procure the necessary medications and supplies for TB control. The program's procurement processes are designed to ensure the availability of quality-assured TB medications, aligning with its goal of providing effective and free TB care to the population.

2Distribution Network

NTP's distribution network spans the entire country, encompassing over 1,700 TB care facilities. These facilities are strategically located in both urban and rural areas to ensure equitable access to TB services. The program's logistics capabilities include a robust supply chain management system that coordinates the procurement, storage, and distribution of TB medications and diagnostic tools. This system is designed to prevent stockouts and ensure timely delivery of essential TB care services across Pakistan. (cmu.gov.pk)

3Industry Role

As a government program, NTP does not function as a pharmaceutical wholesaler, distributor, or importer. Instead, it serves as the central coordinating body for TB control in Pakistan, overseeing the procurement and distribution of TB medications and supplies. The program collaborates with various stakeholders, including international organizations, local suppliers, and provincial health departments, to ensure the effective implementation of TB control strategies nationwide. Its role is pivotal in coordinating efforts to combat TB, ensuring that all TB patients have access to quality diagnosis, treatment, and follow-up care. (cmu.gov.pk)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — National TB Control Program,pakista

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

NTP's procurement strategy involves sourcing TB medications from various suppliers to ensure a consistent and reliable supply chain. While specific data on supplier concentration is not publicly available, the program's collaboration with international organizations and local suppliers suggests a diversified sourcing approach. This strategy mitigates risks associated with single-source dependency and enhances the stability of the supply chain. By engaging multiple suppliers, NTP can maintain a steady supply of quality-assured TB medications, which is crucial for the effective treatment and control of TB in Pakistan.

2Supply Chain Resilience

NTP's supply chain is designed to be resilient, with multiple suppliers and a comprehensive logistics network to ensure the continuous availability of TB medications and diagnostic tools. The program's collaboration with international organizations, such as the Global Fund and the Gates Foundation, provides additional support and resources, enhancing the resilience of the supply chain. By diversifying its supplier base and strengthening its logistics capabilities, NTP can effectively respond to challenges and maintain uninterrupted TB care services across Pakistan. (cmu.gov.pk)

Strategic Implications

Importing Pharmaceuticals into Pakistan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Pakistan

1Regulatory Authority & Framework

The Drug Regulatory Authority of Pakistan (DRAP) is the national regulatory body responsible for ensuring the quality, safety, and efficacy of therapeutic goods in Pakistan. DRAP oversees the import and export of pharmaceutical products, including TB medications, to prevent the infiltration of substandard and falsified products into the supply chain. The regulatory framework governing pharmaceutical imports includes the Drugs Act, 1976, and the DRAP Act, 2012, which outline the procedures and requirements for the importation of therapeutic goods. (dra.gov.pk)

2Import Licensing & GMP

Importers of pharmaceutical products in Pakistan must obtain a Drug Import License (DIL) from DRAP. This license is granted upon submission of an application through DRAP's online portal, accompanied by the requisite documents. Additionally, imported pharmaceutical products must comply with Good Manufacturing Practice (GMP) standards recognized by DRAP. GMP certification ensures that products are consistently produced and controlled according to quality standards, which is essential for maintaining the safety and efficacy of therapeutic goods in the Pakistani market. (dra.gov.pk)

3Quality & Labeling

National TB Control Program,pakista — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

NTP's product strategy focuses on procuring quality-assured TB medications to provide free and effective treatment to TB patients across Pakistan. The program's emphasis on quality and efficacy ensures that imported products meet the necessary standards for patient safety and treatment success. The demand for these products is driven by the high burden of TB in Pakistan, necessitating a reliable supply of effective medications to control and eliminate the disease. (cmu.gov.pk)

2Sourcing Profile

NTP's sourcing strategy involves procuring generic TB medications from various suppliers to ensure a consistent and reliable supply chain. The program's focus on quality-assured formulations aligns with its mission to provide effective TB care to the population. India's pharmaceutical industry, with its capacity to produce high-quality generic medications, fits well into NTP's overall procurement strategy, offering a potential source of supply for TB medications.

3Market Positioning

NTP serves the public sector segment of the Pakistani market, providing free TB care services to the general population. Its focus on quality-assured TB medications and comprehensive care facilities positions it as a key player in the government's efforts to control and eliminate TB in the country. By ensuring equitable access to TB services, NTP contributes significantly to public health and the achievement of national health objectives. (cmu.gov.pk)

Seller's Guide — How to Become a Supplier to National TB Control Program,pakista

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For Indian pharmaceutical suppliers, there is a realistic opportunity to engage with NTP by providing quality-assured TB medications that meet DRAP's regulatory requirements. By aligning with NTP's stringent quality standards and regulatory framework, Indian exporters can establish partnerships that contribute to the global effort to control and eliminate TB. This collaboration can enhance the availability of effective TB treatments in Pakistan, benefiting both the suppliers and the patients in need.

2Requirements & Qualifications

Indian exporters seeking to supply NTP must ensure that their products comply with DRAP's regulatory requirements, including obtaining the necessary Drug Import License and adhering to GMP standards recognized by DRAP. Products must undergo batch testing and stability studies to verify their quality, safety, and efficacy. Labeling must be in the Urdu language, and serialization mandates must be met to enhance traceability and prevent counterfeit products. These qualifications are essential for establishing a successful partnership with NTP and entering the Pakistani market. (dra.gov.pk)

3How to Approach

Frequently Asked Questions — National TB Control Program,pakista

What products does National TB Control Program,pakista import from India?

National TB Control Program,pakista imports 2 pharmaceutical products across 1 categories. Top imports: Pyrazinamide ($350.0K), Ethambutol ($300.0K).

Who supplies pharmaceuticals to National TB Control Program,pakista from India?

National TB Control Program,pakista sources from 1 verified Indian suppliers. The primary supplier is Macleods Pharmaceuticals Limited (100.0% of imports, $373.0K).

What is National TB Control Program,pakista's total pharmaceutical import value?

National TB Control Program,pakista's total pharmaceutical import value from India is $650.0K, based on 13 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does National TB Control Program,pakista focus on?

National TB Control Program,pakista imports across 1 categories. The largest: Tuberculosis Medications (100.0%).

Get Full National TB Control Program,pakista Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.